financetom
Business
financetom
/
Business
/
-- GUIDANCE: (ADBE) Adobe Expects Q2 Revenue Range $6.43B-$6.48B, vs. FactSet Est of $6.43B
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
-- GUIDANCE: (ADBE) Adobe Expects Q2 Revenue Range $6.43B-$6.48B, vs. FactSet Est of $6.43B
Mar 12, 2026 1:32 PM

04:08 PM EDT, 03/12/2026 (MT Newswires) --

Price: 270.22, Change: -3.48, Percent Change: -1.27

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Apollo Global Management Sees Major Earnings Growth in Next Five Years
Apollo Global Management Sees Major Earnings Growth in Next Five Years
Oct 2, 2024
08:40 AM EDT, 10/01/2024 (MT Newswires) -- Apollo Global Management ( APO ) said Tuesday it is expecting 20% average growth in its asset management business and 10% in its retirement unit over the next five years, as demand for private credit and retirement services rises. Adjusted net income is expected to reach $15 per share in the next five...
Augusta Gold Extends Loan Maturity to April 30, 2025
Augusta Gold Extends Loan Maturity to April 30, 2025
Oct 2, 2024
08:43 AM EDT, 10/01/2024 (MT Newswires) -- Augusta Gold ( AUGG ) said Tuesday that it extended the maturity date of its loan with Augusta Investments to April 30, 2025. Augusta Gold ( AUGG ) also agreed to pay a US$71,748 extension fee. In connection with the extension, Augusta Investments will loan Augusta Gold US$5.5 million, an amount equal to...
Kailera Therapeutics nets $400 mln as weight-loss drug market heats up
Kailera Therapeutics nets $400 mln as weight-loss drug market heats up
Oct 2, 2024
Oct 1 (Reuters) - Kailera Therapeutics, a new venture looking to secure a foothold in the booming market for anti-obesity therapies, launched on Tuesday with $400 million in funding from four investors. The startup will be headed by CEO Ron Renaud, who previously led Cerevel Therapeutics - a developer of drugs for neurological conditions - and oversaw its acquisition by...
Stellantis' $854 million UK lawsuit over airbag, seatbelt cartels begins
Stellantis' $854 million UK lawsuit over airbag, seatbelt cartels begins
Oct 2, 2024
LONDON, Oct 1 (Reuters) - Stellantis' ( STLA ) 771 million euro ($854 million) London lawsuit against two safety equipment makers began on Tuesday, with the European carmaker arguing long-running cartels led to it being overcharged for roughly a decade. The automaker, which was formed by the 2021 merger of Fiat Chrysler Automobiles and PSA Group, is suing Autoliv (...
Copyright 2023-2026 - www.financetom.com All Rights Reserved